These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34568726)

  • 1. Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people After ChAdOx1 nCoV-19 vaccination.
    Uaprasert N; Watanaboonyongcharoen P; Vichitratchaneekorn R; Trithiphen S; Akkawat B; Sukperm A; Tongbai T; Jantarabenjakul W; Paitoonpong L; Rojnuckarin P
    Res Pract Thromb Haemost; 2021 Aug; 5(6):e12580. PubMed ID: 34568726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis with thrombocytopenia after the second ChAdOx1 nCoV-19 vaccination: A possible immunological mechanism independent of anti-platelet factor 4 antibody.
    Uaprasert N; Rojnuckarin P
    Asian Pac J Allergy Immunol; 2022 Mar; ():. PubMed ID: 35278060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais.
    Boonyawat K; Phojanasenee T; Noikongdee P; Police P; Chantrathammachart P; Niparuck P; Puavilai T; Phuphuakrat A; Angchaisuksiri P
    Thromb J; 2023 Sep; 21(1):92. PubMed ID: 37674185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of anti-platelet factor 4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais.
    Noikongdee P; Police P; Phojanasenee T; Chantrathammachart P; Niparuck P; Puavilai T; Phuphuakrat A; Angchaisuksiri P; Boonyawat K
    Res Pract Thromb Haemost; 2021 Oct; 5(7):e12600. PubMed ID: 34667921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Profiles of Anti-Platelet Factor 4 Antibodies in Thai People Who Received ChAdOx1 nCoV-19 Vaccination.
    Hantrakun N; Sinsakolwat P; Tantiworawit A; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Wongtagan O; Chaiwarith R; Norasetthada L; Chai-Adisaksopha C
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
    N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.
    Barefah AS; Radhwi OO; Alamri SS; Alahwal HM; Denetiu I; Almohammadi AT; Bahashwan SM; Qari MH; Algaissi A; Alamer E; Alhazmi A; Abuzenadah AM; Nasraldeen WH; Alzahrani SH; Hashem AM
    Int J Lab Hematol; 2022 Apr; 44(2):424-429. PubMed ID: 34850575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study.
    Schultz NH; Søraas AVL; Sørvoll IH; Akkök ÇA; Vetlesen A; Bhamra JS; Ahlen MT; Holme PA; Aamodt AH; Skagen K; Skattør TH; Skjelland M; Wiedmann MK
    J Stroke Cerebrovasc Dis; 2023 Jan; 32(1):106860. PubMed ID: 36403363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Thiele T; Ulm L; Holtfreter S; Schönborn L; Kuhn SO; Scheer C; Warkentin TE; Bröker BM; Becker K; Aurich K; Selleng K; Hübner NO; Greinacher A
    Blood; 2021 Jul; 138(4):299-303. PubMed ID: 33988688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination.
    Sørvoll IH; Horvei KD; Ernstsen SL; Laegreid IJ; Lund S; Grønli RH; Olsen MK; Jacobsen HK; Eriksson A; Halstensen AM; Tjønnfjord E; Ghanima W; Ahlen MT
    J Thromb Haemost; 2021 Jul; 19(7):1813-1818. PubMed ID: 33909350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.
    Platton S; Bartlett A; MacCallum P; Makris M; McDonald V; Singh D; Scully M; Pavord S
    J Thromb Haemost; 2021 Aug; 19(8):2007-2013. PubMed ID: 33973336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)-Insights from Clinical Cases, In Vitro Studies and Murine Models.
    Dabbiru VAS; Müller L; Schönborn L; Greinacher A
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis.
    Dorgalaleh A; Shabannezhad A; Hassani S
    Ann Hematol; 2023 Nov; ():. PubMed ID: 38030893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
    Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA
    Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
    Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
    Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination.
    Comer SP; Le Chevillier A; Szklanna PB; Kelliher S; Saeed K; Cullen S; Edebiri O; O'Neill T; Stephens N; Weiss L; Murphy CA; Rajakumar S; Tierney A; Hughes C; Lennon Á; Moran N; Maguire PB; Ní Áinle F; Kevane B
    Front Cardiovasc Med; 2022; 9():824601. PubMed ID: 35224056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.